K Number
K013504
Device Name
MODIFICATION TO: ECAT LSO PET/CT SCANNER
Date Cleared
2001-10-31

(9 days)

Product Code
Regulation Number
892.1200
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The CPS/Siemens ECAT LSO PET/CT system is a combined positron emission tomography (PET) and Xray computed tomography (CT) scanner. The ECAT LSO PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles. The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image. (*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient. }
Device Description
The ECAT LSO PET/CT is a combined position emission tomography (PET) and X-ray computed tomography (CT) scanner. This dual modality tomograph is a modified version of the ECAT PET/CT (K002715) and will utilize the same CT component from the Siemens SOMATOM EMOTION (CT) Scanner. However, in place of the PET component that uses 288 BGO crystal block detectors, the ECAT LSO PET/CT will be configured with the CPS ECAT ACCEL PET (K002584) using 144 LSO crystal block detectors, in combination with the Siemens Somatom EMOTION CT. As with the predicate system, 2D PET acquisition and the PET transmission sources are not included in the modified ECAT LSO PET/CT. PET acquisition data is acquired only in 3D and PET attenuation correction map data is obtained from the CT. The PET and CT components will be integrated as in the original ECAT PET/CT to create an integrated, PET, CT, and combined PET/CT, tomographic imaging system. The ECAT LSO PET/CT gantry structure, patient handling system (PHS), advanced computational system (ACS 3), and workstations will remain essentially the same as the ECAT PET/CT system with only minor modifications to accommodate the different PET detectors. In addition, the ECAT LSO PET/CT as well as the HR+ based ECAT PET/CT will also be offered with either the Siemens single slice EMOTION CT (K991764) or the dual slice EMOTION MS CT (K003074), for the CT component of the system. The EMOTION MS CT with two rows of X-ray detectors does not otherwise affect performance of the ECAT LSO PET/CT.
More Information

No
The document describes a combined PET/CT scanner and its components, focusing on hardware modifications and integration. There is no mention of AI, ML, or related concepts in the intended use, device description, or the specific sections checked for these terms.

No.
The device is described as an imaging system used for diagnostic purposes, not for treating diseases or conditions.

Yes

This device is a combined PET/CT scanner designed to image and measure the distribution of radiopharmaceuticals to determine metabolic and physiologic functions, and to produce cross-sectional images using x-ray transmission data. These functions are inherently diagnostic as they provide information used to diagnose conditions within the human body.

No

The device description clearly states it is a combined PET and CT scanner, which are hardware components. It also mentions a gantry structure, patient handling system, and workstations, all of which are physical hardware.

Based on the provided information, this device is not an In Vitro Diagnostic (IVD).

Here's why:

  • Intended Use: The intended use clearly states that the system is used to "image and measure the distribution of injected positron emitting radiopharmaceuticals in humans" and "to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data". This describes an in vivo imaging system, meaning it is used to examine the inside of a living body.
  • Device Description: The description details a PET/CT scanner, which is a type of medical imaging equipment used directly on patients.
  • Lack of IVD characteristics: There is no mention of analyzing biological samples (like blood, urine, tissue) outside of the body, which is the defining characteristic of an IVD.

Therefore, the ECAT LSO PET/CT system is a medical imaging device used for in vivo diagnosis, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The CPS/Siemens ECAT LSO PET/CT system is a combined positron emission tomography (PET) and Xray computed tomography (CT) scanner. The ECAT LSO PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.

The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.

(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)

Product codes (comma separated list FDA assigned to the subject device)

90 KPS

Device Description

The ECAT LSO FETICT is a combined position emission tomography (PET) and X-ay computed tomography (CT) scanner. This dual modality tomograph is a modified version of the ECAT P (K002715) and will utilize the same CT component from the Siemens SOMATOM Project 10 (1002713) and will unite the same CT Component from PET component that uses 288 BGO EMOTION (CT) Scanner. Thowever, in place of and Lee configured with the CPS ECAT ACCEL PET crystal block detectors, the ECAT LSO PET/CT will be configured with the Cliences S (K002584) using 144 LSO crystal block detectors, in combination with the Siemens Somation of the (KUU2384) using 144 LSO crystal block accessions and the PET transmission sources are not As with the predicale system, 2D I ET acquisition data is acquired only in 3D and PET
included in the modified ECAT LSO PET/CT. PET employees and externill be attenuation correction map data is obtained from the CT. The PET and CT components will be attenuation correction map cata is obusined from the original ECAT PET/CT to create an integrated, PET, CT, and combined PET/CT, tomographic imaging system.

The ECAT LSO PET/CT gantry structure, patient handling system (PHS), advanced computational The ECAT LSO I ETCT gainly stractare, pail remain essentially the same as the ECAT PET/CT system (ACS 3), workslations to accommodate the different PET detectors. In addition, the ECAT with only imilor modifications to acconmisear. ITT will also be offered with either the Siemens. LSO PET/CT as well as the HR+ based ECAT PET/CT will also be offered of MC LSO FETCT as well as the First based inthe dual slice Duo version, SOMATON EMOTION MS single slice EMOTION CT (K991764) or the dual slice interest of X reverse of X rev single silce EMOTION Of the system. The EMOTION MS CT with two rows of X-ray (KU030T+), for the CT component of the System. The Execue of otherwise affect performance of the ECAT LSO PET/CT.

The ECAT LSO PET/CT scanner is intended for use primarily as a clinical, whole-body oncology machine with mid-range spiral CT performance and fast patient-throughput clinical PET performance. The CT component will also enhance PET scans by allowing fast, essentially noise-free attenuation correction for PET studies, and by providing precise anatomical reference through fused PET and CT images. In addition, the ECAT LSO PET/CT will retain mechanical isolation and independent functionality of the PET and CT scanning systems, thereby allowing for most standard CT and PET clinical diagnostic protocols to be available on the PET/CT system.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Positron Emission Tomography (PET), X-Ray Computed Tomography (CT)

Anatomical Site

Human body

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Appropriately trained health care professionals, clinical setting

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K002715

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K002713, K002584, K991764, K00307+

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.1200 Emission computed tomography system.

(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.

0

K01 3504
Page 1 of 2

510(k) SUMMARY

[As required by 21 CFR 807.87(h)]

Identification of Submitter

Submitter:

Telephone No: Fax No: Date of preparation:

Identification of the Product

Device Proprietary Name: Common Name:

Classification Name:

William Skremsky CTI PET Systems, Inc. 810 Innovation Drive Knoxville, TN 37932 (865) 218-2522 (865) 218-3000 October 8, 2001

ECAT LSO PET/CT Scanner Combination Positron Emission Tomography (PET) and X-Ray Computed Tomography (CT) Emission Computed Tomography System per 21 CFR 892.1200

Marketed Device to Which Equivalence is Claimed

DeviceManufacturer510(k) Number
ECAT PET/CTCTI PET Systems (CPS)K002715

Device Description and Comparison

Device Description and Comparison emission tomography (PET) and X-ay computed The BCAT LSO FETICT is a combined position is a modified version of the ECAT PET/CT
tomography (CT) scanner. This dual modality tomograph is a modified version of the ECAT P (K002715) and will utilize the same CT component from the Siemens SOMATOM Project 10 (1002713) and will unite the same CT Component from PET component that uses 288 BGO EMOTION (CT) Scanner. Thowever, in place of and Lee configured with the CPS ECAT ACCEL PET
crystal block detectors, the ECAT LSO PET/CT will be configured with the Cliences S (K002584) using 144 LSO crystal block detectors, in combination with the Siemens Somation of the (KUU2384) using 144 LSO crystal block accessions and the PET transmission sources are not As with the predicale system, 2D I ET acquisition data is acquired only in 3D and PET
included in the modified ECAT LSO PET/CT. PET employees and externill be attenuation correction map data is obtained from the CT. The PET and CT components will be attenuation correction map cata is obusined from the original ECAT PET/CT to create an integrated, PET, CT, and combined PET/CT, tomographic imaging system.

The ECAT LSO PET/CT gantry structure, patient handling system (PHS), advanced computational The ECAT LSO I ETCT gainly stractare, pail remain essentially the same as the ECAT PET/CT system (ACS 3), workslations to accommodate the different PET detectors. In addition, the ECAT with only imilor modifications to acconmisear. ITT will also be offered with either the Siemens.
LSO PET/CT as well as the HR+ based ECAT PET/CT will also be offered of MC LSO FETCT as well as the First based inthe dual slice Duo version, SOMATON EMOTION MS
single slice EMOTION CT (K991764) or the dual slice interest of X reverse of X rev single silce EMOTION Of the system. The EMOTION MS CT with two rows of X-ray (KU030T+), for the CT component of the System. The Execue of otherwise affect performance of the ECAT LSO PET/CT.

1

510(k) Summary ECAT LSO PET/CT Scanner p. 2

K013504
Page 2 of 2

The ECAT LSO PET/CT scanner is intended for use primarily as a clinical, whole-body oncology machine with mid-range spiral CT performance and fast patient-throughput clinical PET performance. The CT component will also enhance PET scans by allowing fast, essentially noise-free attenuation correction for PET studies, and by providing precise anatomical reference through fused PET and CT images. In addition, the ECAT LSO PET/CT will retain mechanical isolation and independent functionality of the PET and CT scanning systems, thereby allowing for most standard CT and PET clinical diagnostic protocols to be available on the PET/CT system.

Indications for Use

The CPS/Siemens ECAT PET/CT system is a combined positron emission tomography (PET) and Xray computed tomography (CT) scanner. The PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected position emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.

The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.

(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of a caduceus, which is a symbol of medicine and health. The caduceus is depicted as a staff with two snakes coiled around it and wings at the top.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

OCT 31 7001

Mr. William Skremsky Senior Regulatory Affairs Specialist CTI, Inc. 810 Innovation Drive KNOXVILLE TENNESSEE 37932 Re: K013504 Trade/Device Name: Modification to: ECAT LSO PET/CT Scanner Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system

Regulatory Class: II Product Code: 90 KPS Dated: October 18, 2001 Received: October 22, 2001

Dear Mr. Skremsky:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

3

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

8xx.1xxx(301) 594-4591
876.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4616
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx(301) 594-4616
892.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4654
Other(301) 594-4692

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Page _ / of _ /

5

510(k) Number (if known):

Device Name: ECAT LSO PET/CT Scanner

Indications for Use:

The CPS/Siemens ECAT LSO PET/CT system is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner. The ECAT LSO PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.

The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.

(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient. }

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription UseOROver-The-Counter Use ______
(Per 21 CFR 801.109)
Nancy Brogdon(Optional Format 1-2-96)
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) NumberK013504